Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-000808
Filing Date
2022-02-04
Accepted
2022-02-04 16:05:49
Documents
97
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q lci-20211231x10q.htm   iXBRL 10-Q 2102779
2 EX-31.1 lci-20211231xex31d1.htm EX-31.1 10356
3 EX-31.2 lci-20211231xex31d2.htm EX-31.2 10422
4 EX-32 lci-20211231xex32.htm EX-32 7988
  Complete submission text file 0001558370-22-000808.txt   9874301

Data Files

Seq Description Document Type Size
5 EX-101.SCH lci-20211231.xsd EX-101.SCH 59248
6 EX-101.CAL lci-20211231_cal.xml EX-101.CAL 73186
7 EX-101.DEF lci-20211231_def.xml EX-101.DEF 214635
8 EX-101.LAB lci-20211231_lab.xml EX-101.LAB 606923
9 EX-101.PRE lci-20211231_pre.xml EX-101.PRE 462477
91 EXTRACTED XBRL INSTANCE DOCUMENT lci-20211231x10q_htm.xml XML 2099432
Mailing Address 9000 STATE ROAD 9000 STATE ROAD PHLADELPHIA PA 19136
Business Address 9000 STATE RD PHILADELPHIA PA 19136 2153339000
LANNETT CO INC (Filer) CIK: 0000057725 (see all company filings)

EIN.: 230787699 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-31298 | Film No.: 22593256
SIC: 2834 Pharmaceutical Preparations